DANA-FARBER CANCER INSTITUTE BOSTON – Prompted by a recent alarming rise in cases of colorectal cancer in people younger than 50, an independent expert panel has recommended that individuals of average risk for the disease begin screening exams at 45 years of age instead of the traditional 50. The guideline changes by the U.S. Preventive...
Month: <span>May 2021</span>
Post
Entirely new class of biomolecule may be common to all forms of life
By Michael Irving May 17, 2021 A model of the surface of a cell, including gycoproteins (yellow), which are related to the newly discovered biomolecule, glycoRNAanimaxx3d/Depositphotos Scientists continue to make surprising discoveries in our own bodies. Stanford researchers have now discovered a new biomolecule hiding in plain sight, which may be common to most types...
Post
Cysteinylated albumin new early diagnostic marker for diabetic kidney disease
by Kumamoto University Mass spectrometer analysis of blood serum in diabetic patients. 1) SH-Albumin (unmodified), 2) Cys-Albumin (cysteine adduct (oxidized albumin), 3) Glu-Albumin (sugar adduct), 4) Cys-Glu-Albumin (simultaneous cysteine and sugar adduct), 5) Glu-Glu-Albumin (two sugar adducts). Credit: Associate Professor Hiroshi Watanabe A research group from Kumamoto University, Japan has discovered that cysteinylated albumin (oxidized albumin)...
Post
Clopidogrel superior to aspirin for long-term post-stent maintenance
by American College of Cardiology Credit: CC0 Public Domain Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse events after one year of dual antiplatelet therapy (DAPT) following the insertion of...
Post
“Holy Grail” – Hyperbaric Oxygen Treatments Reverse Aging Process in First Clinical Trial
By AMERICAN FRIENDS OF TEL AVIV UNIVERSITY JANUARY 19, 2021 Credit: Shamir Medical Center Study finds hyperbaric oxygen treatments halt the aging of blood cells and reverses the aging process. A new study from Tel Aviv University (TAU) and the Shamir Medical Center in Israel indicates that hyperbaric oxygen treatments (HBOT) in healthy aging adults can stop...
Post
Israeli scientists find natural food supplement that could treat anxiety
By JERUSALEM POST STAFF MAY 21, 2021 12:48 Stress, illustrative(photo credit: PIXNIO) A natural plant-derived food supplement could possibly be used to help reduce anxiety, a new study from Israel’s Weizmann Institute of Science has found.The substance, beta-sitosterol, was shown in the study to reduce anxiety in mice, and was found to produce this effect both by...
Post
Itch insight: Skin itch mechanisms differ on hairless versus hairy skin
by Georgia Institute of Technology These mouse hindpaw sections allow Georgia Tech researchers to visualize skin nerves. Credit: Christopher Moore, Georgia Tech Chronic skin itching drives more people to the dermatologist than any other condition. In fact, the latest science literature finds that 7% of U.S. adults, and between 10 and 20% of people in developed countries, suffer...
Post
Semaglutide New Drug Combo Well-Tolerated, Leads to Weight Loss
Becky McCall May 19, 2021 Combining an investigational agent, cagrilintide (Novo Nordisk), with semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, leads to greater weight loss than semaglutide alone in people with a body mass index (BMI) over 27 kg/m2, and the combination was well-tolerated, shows a phase 1 study. The research was presented at the online ECO 2021 meeting by Lone...
Post
Protein-based vaccines against SARS-CoV-2 may provide advantages over mRNA-based vaccines
By Sally Robertson, B.Sc. May 20 2021 Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19). The team – from the University of Liverpool and the MRC Laboratory of...
Post
A brand new cocktail to fight HIV
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a “molecular can opener” and a combination of antibodies found in the blood of infected individuals. In their study published in Cell Host & Microbe, the team of scientists, in...